Nuclein

Austin, TX · Founded 2017 · Privately Held (backing)

Developer of a rapid PCR testing system designed to deliver lab results at the point of care. Nuclein is based in Austin, TX and was founded in 2017. It has raised $67.3 million across 5 recorded rounds; the latest was a $1.3 million debt round in Jun 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$67.3M
Last round
Debt
Jun 2026
How much has Nuclein raised?
$67.3Macross 5 recorded rounds · Aug 2019 – Jun 2026

Most recently, Nuclein raised $1.3M in its Debt (Jun 2026).

Free account
More of Nuclein with a free account
  • ·Watch Nuclein: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nuclein round by round

5 rounds
Jun 2026Debt$1.3MSEC filing▮
2 investors participated
Jun 2025Debt$19.1MSEC filing▮
49 investors participated
Jan 2025Early Stage VC$9.4MSEC filing▮
34 investors participated
Nov 2023Debt$8.8MSEC filing▮
18 investors participated
Aug 2019Seed Round$420KSEC filing▮
10 investors participated

How much has Nuclein raised?

Nuclein has raised $67.3 million across 5 recorded rounds since 2019. The largest was a $9.4 million early-stage round in Jan 2025; the most recent was a $1.3 million debt round in Jun 2026.

Nuclein has filed 10 Form Ds with the SEC since 2019, most recently in Dec 2025 ($14.9 million sold to 42 investors).

Nuclein investors

9 investors are on record for Nuclein, including Alan Richey, ACC Bioscience Incubator, David Shockley and Dr. John Butler. The debt round in Jun 2026 drew 2 investors.

For fundraisers
Raising for a company like Nuclein?

9 investors have backed Nuclein.

See all 9 investors →

Frequently asked about Nuclein

How much has Nuclein raised?
Nuclein has raised $67.3M in total across 5 recorded funding rounds.
When was Nuclein's last funding round?
Nuclein's most recent recorded round was Debt in Jun 2026, raising $1.3M.